Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: SYNEDGEN, INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2024-09-20 to 2026-09-19
Current total value of award: $2297415
Description: SBIR PHASE III PROPOSAL NO. JW230017 TO FURTHER DEVELOP AN ORALLY DELIVERED DRUG PRODUCT TO TREAT INJURY TO, AND INFLAMMATION OF, THE GASTROINTESTINAL TRACT.